Pages that link to "Item:Q2864025"
From MaRDI portal
The following pages link to A cross-validation study to select a classification procedure for clinical diagnosis based on proteomic mass spectrometry (Q2864025):
Displaying 14 items.
- Binary Markov random fields and interpretable mass spectra discrimination (Q523937) (← links)
- On the use of double cross-validation for the combination of proteomic mass spectral data for enhanced diagnosis and prediction (Q544613) (← links)
- Feature selection and machine learning with mass spectrometry data for distinguishing cancer and non-cancer samples (Q713690) (← links)
- A new genetic algorithm in proteomics: feature selection for SELDI-TOF data (Q1023781) (← links)
- Prototype based fuzzy classification in clinical proteomics (Q2270370) (← links)
- Organizing a competition on clinical mass spectrometry based proteomic diagnosis (Q2864012) (← links)
- Developing a discrimination rule between breast cancer patients and controls using proteomics mass spectrometric data: a three-step approach (Q2864014) (← links)
- Principal component discriminant analysis (Q2864015) (← links)
- Classification of breast cancer versus normal samples from mass spectrometry profiles using linear discriminant analysis of important features selected by random forest (Q2864016) (← links)
- A classification model for the Leiden proteomics competition (Q2864018) (← links)
- Support vector machine approach to separate control and breast cancer serum samples (Q2864022) (← links)
- Breast cancer diagnosis from proteomic mass spectrometry data: a comparative evaluation (Q2864029) (← links)
- Sample size calculations for designing clinical proteomic profiling studies using mass spectrometry (Q2921247) (← links)
- International Competition on Mass Spectrometry Proteomic Diagnosis (Q5396467) (← links)
